000 01156 a2200313 4500
005 20250514231239.0
264 0 _c20051110
008 200511s 0 0 eng d
022 _a0263-6352
024 7 _a10.1097/01.hjh.0000173511.30116.89
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBrain, Nick
245 0 0 _aPharmacogenomics in hypertension: present practicalities and future potential.
_h[electronic resource]
260 _bJournal of hypertension
_cJul 2005
300 _a1327-9 p.
_bdigital
500 _aPublication Type: Comment; Editorial
650 0 4 _aAdrenergic beta-Antagonists
_xtherapeutic use
650 0 4 _aAngiotensin-Converting Enzyme Inhibitors
_xtherapeutic use
650 0 4 _aBlood Pressure
_xdrug effects
650 0 4 _aDiuretics
_xtherapeutic use
650 0 4 _aHaplotypes
650 0 4 _aHumans
650 0 4 _aHypertension
_xdrug therapy
650 0 4 _aPharmacogenetics
650 0 4 _aPolymorphism, Genetic
700 1 _aDominiczak, Anna F
773 0 _tJournal of hypertension
_gvol. 23
_gno. 7
_gp. 1327-9
856 4 0 _uhttps://doi.org/10.1097/01.hjh.0000173511.30116.89
_zAvailable from publisher's website
999 _c15602438
_d15602438